
Silo Pharma
(NASDAQ) SILO
Silo Pharma Financials at a Glance
Market Cap
$10.09M
Revenue (TTM)
$72.10K
Net Income (TTM)
$4.23M
EPS (TTM)
$-0.61
P/E Ratio
-1.02
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$0.61
Volume
0
Open
$0.61
Price
$0.61
Volume
0
Open
$0.61
Previous Close
$0.61
Daily Range
$0.57 - $0.64
52-Week Range
$0.22 - $1.19
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$0.61
Volume
0
Open
$0.61
Previous Close
$0.61
Daily Range
$0.57 - $0.64
52-Week Range
$0.22 - $1.19
SILO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Silo Pharma
Industry
Biotechnology
Sector
Health CareEmployees
3
CEO
Eric Weisblum
Website
www.silopharma.comHeadquarters
Sarasota, FL 34236, US
SILO Financials
Key Financial Metrics (TTM)
Gross Margin
-6%
Operating Margin
-59%
Net Income Margin
-59%
Return on Equity
-75%
Return on Capital
-62%
Return on Assets
-56%
Earnings Yield
-98.04%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.09M
Shares Outstanding
16.27M
Volume
0
Short Interest
0.00%
Avg. Volume
4.73M
Financials (TTM)
Gross Profit
$813.96K
Operating Income
$4.28M
EBITDA
$4.28M
Operating Cash Flow
$4.66M
Capital Expenditure
$0.00
Free Cash Flow
$4.66M
Cash & ST Invst.
$6.86M
Total Debt
$0.00
Silo Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$18.03K
+0.0%
Gross Profit
$235.02K
+38.5%
Gross Margin
-13.04%
N/A
Market Cap
$10.09M
N/A
Market Cap/Employee
$3.36M
N/A
Employees
3
N/A
Net Income
$881.53K
+49.1%
EBITDA
$783.59K
+56.3%
Quarterly Fundamentals
Net Cash
$6.86M
-3.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-55.59%
N/A
Return on Invested Capital
-61.55%
N/A
Free Cash Flow
$780.28K
+14.9%
Operating Cash Flow
$780.28K
+14.9%